The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Craig Adam R since 2014.
This trader's CIK number is 1339498.
At the time of last reporting, Craig Adam R was the President and CEO of Cti Biopharma Corp. (stock ticker symbol CTIC).
Also see all insider trading activities at Cti Biopharma Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | SNSS | 0 | $0 | 2,554 | $20,432 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | CTIC | 0 | $0 | 115,583 | $694,683 | 115,583 | $97,204 |
| 2022 | CTIC | 5,000 | $27,500 | 144,446 | $868,862 | 144,446 | $121,478 |
| 2021 | CTIC | 3,500 | $5,337 | 0 | $0 | 0 | $0 |
1. Viracta Therapeutics, Inc. (SNSS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-27 | SNSS | Sale | 2,554 | 8.00 | 20,432 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-01-03 | CTIC | Option Ex | 84,683 | .84 | 71,218 |
| 2022-12-30 | CTIC | Sale | 17,100 | 6.00 | 102,685 |
| 2022-12-29 | CTIC | Sale | 13,800 | 6.00 | 82,800 |
| 2023-01-03 | CTIC | Sale | 84,683 | 6.01 | 509,198 |
| 2022-12-30 | CTIC | Option Ex | 17,100 | .84 | 14,381 |
| 2022-12-29 | CTIC | Option Ex | 13,800 | .84 | 11,605 |
| 2022-08-16 | CTIC | Buy | 5,000 | 5.50 | 27,500 |
| 2022-07-01 | CTIC | Sale | 27,000 | 6.00 | 162,000 |
| 2022-07-05 | CTIC | Option Ex | 27,000 | .84 | 22,707 |
| 2022-07-06 | CTIC | Option Ex | 18,223 | .84 | 15,325 |
| 2022-07-05 | CTIC | Sale | 27,000 | 6.00 | 162,000 |
| 2022-07-06 | CTIC | Sale | 18,223 | 6.11 | 111,342 |
| 2022-07-01 | CTIC | Option Ex | 27,000 | .84 | 22,707 |
| 2022-06-03 | CTIC | Sale | 18,223 | 6.01 | 109,520 |
| 2022-06-02 | CTIC | Sale | 27,000 | 6.00 | 162,000 |
| 2022-06-03 | CTIC | Option Ex | 18,223 | .84 | 15,325 |
| 2022-06-01 | CTIC | Sale | 27,000 | 6.00 | 162,000 |
| 2022-06-02 | CTIC | Option Ex | 27,000 | .84 | 22,707 |
| 2022-06-01 | CTIC | Option Ex | 27,000 | .84 | 22,707 |
| 2021-12-02 | CTIC | Buy | 3,500 | 1.52 | 5,337 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Craig Adam R (President and CEO of Cti Biopharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.